Cerecor Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Cerecor Contact Number

Cerecor Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Show details

410-522-8707Contact Email [email protected]cerecor.com Phone Number 410-522-8707 Cerecor is a biopharmaceutical company focused on becoming a leader in the development and …

Founded: 2011

Category: Contact NumberShow more

FAQ :: Avalo Therapeutics, Inc. (AVTX) Cerecor, Inc.

6 hours ago Ir.avalotx.com Show details

(610) 254-4201Avalo is headquartered at 1500 Liberty Ridge Drive Suite 321 Wayne, PA 19087. The main phone number is (610) 254-4201. Where was Avalo incorporated? Avalo was incorporated in the state of Delaware in 2011. When did Avalo (formerly Cerecor inc.) go public and on which exchange is it listed?

Category: Contact NumberShow more

Cerecor, Inc. (CERC) Avalo Therapeutics, Inc. (AVTX)

4 hours ago Avalotx.com Show details

About Us. We are a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in the areas of immunology, immuno-oncology and rare disease.

Category: Contact NumberShow more

Cerecor Company Profile Office Locations, Competitors

4 hours ago Craft.co Show details

Cerecor is a clinical-stage biopharmaceutical company, which develops drugs to treat patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use …

Employees: 18
Type: Public
Founded: 2011
Website: cerecor.com

Category: Contact NumberShow more

Change Address or Representation Form for Cerecor

1 hours ago Uspto.report Show details

DOCKET/REFERENCE NUMBER (S) 029492.029. OWNER SECTION (proposed) STATEMENT TEXT. By submission of this request, the undersigned requests that the following be made of record for the owner/holder: NAME. Cerecor Inc. MAILING ADDRESS. 373 Iverness Parkway.

ATTORNEY BAR MEMBERSHIP NUMBER: XXX
U.S. STATE/ COMMONWEALTH/ TERRITORY: XX
NAME: Devon E. White
YEAR OF ADMISSION: XXXX

Category: Contact NumberShow more

CDOCS Contact Us

9 hours ago Cdocs.com Show details

CDOCS is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing education programs of this program provider are accepted by the AGD for Fellowship/Mastership and membership maintenance credit.

Category: Contact SupportShow more

Document SEC.gov HOME

Just Now Sec.gov Show details

Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. or contact your broker, bank, dealer or other agent to request a proxy form. Cerecor Inc., 540 Gaither Road, Suite 400, Rockville, Maryland 20850, giving the information required in our bylaws, including, among other things

Category: Home PhoneShow more

Cerecor Inc. (Form: 8K, Received: 12/05/2019 16:22:29)

7 hours ago Content.edgar-online.com Show details

280-19-0147Cerecor will retain its public reporting and current NASDAQ listing status. less an amount of up to $500,000, divided by the number of fully diluted shares of Aevi common stock immediately prior to if necessary, contact with such third party to clarify the terms and conditions of such Takeover Proposal), constitutes or would reasonably

Category: Contact NumberShow more

Cerecor Inc. (Form: 8K, Received: 10/15/2019 16:11:36)

8 hours ago Content.edgar-online.com Show details

280-19-0122On October 10, 2019, Cerecor Inc. that number of shares of Aytu Preferred Stock that is equal to the total number of Stock Consideration Shares; and (including minutes and official contact reports of communications with any applicable Regulatory Authority) and all material supporting documents, in each case as requested by Buyer.

Category: Contact NumberShow more

CERC Cerecor Stock Profile Barchart.com

1 hours ago Barchart.com Show details

It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million. Shares Outstanding, K: Common shares outstanding as reported by the company on the 10-Q or 10-K.

Category: Contact NumberShow more

Cerecor Announces U.S. Headquarters Move Into

7 hours ago Ir.avalotx.com Show details

Cerecor is in a period of organizational transformation and these new facilities aid in employee recruitment and teamwork, as we have a number of significant clinical and commercial milestones to deliver on in 2019.” 2019 is poised to be a significant year for Cerecor.

Category: Contact NumberShow more

Preclinical Development of a Novel and Effective Treatment

5 hours ago Sbir.gov Show details

(410) 522-8707Name: MARK GINSKI Phone: (410) 522-8707 Email: [email protected]

Category: Contact NumberShow more

A Pharmacokinetic, Pharmacodynamic, Safety and

1 hours ago Clinicaltrials.gov Show details

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04994002

Category: Contact NumberShow more

Early Stage Development of a Selective Kappa Opioid

6 hours ago Sbir.gov Show details

Agency Tracking Number: U44AA025253. Amount: $ Business Contact. Name: AMANDA BOURGEOIS month safety study with CERC EC in minipigs and file an IND with FDAandapos s DAAAP for the treatment of AUDs Cerecor will conduct a pharmacokinetic PK study in healthy humans that will assess the bioavailability and PK profile of the CERC EC compare

Category: Contact NumberShow more

Cerecor and Myriad Genetics Announce that Levels of Novel

8 hours ago Myriadrbm.com Show details

(801) 584-3065Hackensack University Medical Center was listed as the number one hospital in New Jersey in U.S. News & World Report’s 2017-18 Best Hospital rankings – maintaining its place atop the NJ rankings since the rating system was introduced. Cerecor Media and Investor Contact: James Harrell (801) 584-3065 [email protected] Myriad Media and

Category: Contact NumberShow more

Jobs with Cerecor Inc BioSpace

3 hours ago Biospace.com Show details

Cerecor Inc. Announces Pricing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants. 1/8/2021. Cerecor Inc., a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced that it has entered into an underwriting agreement with Jefferies LLC under which the …

Category: Contact NumberShow more

Document SEC.gov HOME

Just Now Sec.gov Show details

You are cordially invited to attend the 2021 Annual Meeting of Stockholders (the “Annual Meeting”) of Cerecor Inc., a Delaware corporation (the “Company”), which will be held on Tuesday, June 15, 2021, at 9:30 a.m. Eastern Time. Due to the public health impact of the COVID-19 pandemic and to support the health and well-being of our stockholders, directors, employees and our community

Category: Home PhoneShow more

Cerecor Announces New Worldwide License Agreement with

4 hours ago Ca.finance.yahoo.com Show details

It is the only clinical stage anti-LIGHT therapy and has the potential to treat a number of LIGHT-associated immune diseases including cytokine storm-induced COVID-19 ARDS. It is currently in development for pediatric onset Crohn’s disease and cytokine storm induced COVID-19 ARDS. Cerecor has also developed a validated, high sensitivity serum

Category: Contact NumberShow more

Contact Us – REGENXBIO

3 hours ago Regenxbio.com Show details

Contact Us. * Required Information. Name *. First Last. Email *. Country. United States Afghanistan Albania Algeria American Samoa Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei

Category: Contact SupportShow more

CERC Company Profile for CERECOR INC. MSN Money

1 hours ago Msn.com Show details

Cerecor, Inc. is a biopharmaceutical company. The Company is focused on development and commercialization of treatments for pediatric and orphan diseases. Its pediatric rare disease pipeline is

Category: Contact NumberShow more

CERC Insider Buying and Selling (Cerecor) MarketBeat

1 hours ago Marketbeat.com Show details

Cerecor (NASDAQ:CERC) Insider Buying and Selling Activity. 45.70% of Cerecor's shares are owned by company executives, directors and other insiders. Over the past twelve months, Cerecor insiders have purchased shares 12 time (s), totalling $7,502,165.92. Insiders that have bought shares include Armistice Capital Llc, Armistice Capital Llc

Category: Contact NumberShow more

Cerecor Inc. (CERC):Buy today, is the recommendation of

1 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 96.18 million. CERC does have institutional investors; and they hold 70.40% of the stock. Cerecor Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 9 new insider purchases involving 212,749 shares.

Category: Contact NumberShow more

Cereclor 51L, CAS Number: 63449398

2 hours ago Chemindustry.com Show details

Cereclor 51L - chemical information, properties, structures, articles, patents and more chemical data.

Category: Contact NumberShow more

Cerecor Inc. Announces Closing of $37.95 Million Public

5 hours ago Cnn.com Show details

The shares of common stock described above were offered by Cerecor pursuant to an effective shelf registration statement on Form S-3 (File No. 333-233978), previously filed with the U.S

Category: Contact NumberShow more

CERCUT 13F Hedge Fund and Asset Management Owners

5 hours ago Whalewisdom.com Show details

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases.

Category: Contact NumberShow more

Cerecor : Avalo Therapeutics, Inc. Announces Corporate

8 hours ago Marketscreener.com Show details

“The rebranding from Cerecor to Avalo Therapeutics comes at a defining moment in our Company's history and better reflects who we are today with our increased focus on immunology, immuno-oncology, and rare genetic diseases," said Michael F. Cola, President and Chief Executive Officer of Avalo Therapeutics.

Category: Contact NumberShow more

Innocrin Pharmaceuticals Crunchbase Company Profile

4 hours ago Crunchbase.com Show details

(919) 467-8539Phone Number (919) 467-8539 Innocrin discovers and develops novel oral inhibitors of CYP17 lyase, a validated enzyme target for the treatment of prostate cancer. The company offers CYP17 lyase, a validated enzyme target for the treatment of CRPC and other hormonally-driven conditions, such as breast cancer, endometriosis, or congenital adrenal

Category: Contact NumberShow more

PART A: Efficacy and Safety of AEVI001 in Children and

7 hours ago Clinicaltrials.gov Show details

A Multicenter, 2-Part, 6-Week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of AEVI-001 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Implicated in Glutamatergic Signaling and Neuronal

Category: Contact NumberShow more

CEREC CAD/CAM solutions for dental practices Dentsply

8 hours ago Dentsplysirona.com Show details

Customer Service. Exit Registration . Are you sure you want to leave this page? You have unsaved changes that will be lost if you decide to continue. Cancel Continue Created with Sketch. Created with Sketch. Created by potrace 1.15, written by Peter Selinger 2001-2017 Created with Sketch. PRESS Created with Sketch.

Category: Contact NumberShow more

Cerecor Stock Today AVTX Macroaxis

4 hours ago Macroaxis.com Show details

Cerecor is trading at 2.12 as of the 5th of October 2021; that is -0.93 percent decrease since the beginning of the trading day. The stock's open price was 2.14. Get the latest Cerecor detailed stock quotes, stock trade data, stock price info, and performance analysis, including Cerecor Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

Cerecor Reports First Quarter 2021 Financial Results and

Just Now Finance.yahoo.com Show details

First Quarter 2021 Financial Update: Story continues. As of March 31, 2021, Cerecor had $38.3 million in cash and cash equivalents, which was a …

Category: Contact NumberShow more

James Broomfield Consultant Private Company LinkedIn

2 hours ago Uk.linkedin.com Show details

Possessing exceptional analytical skills, James understands how to improve performance whilst making efficiences. A true customer champion with a natural willingness to collaborate for success. James has a confidence that reassures, a personality that engages you and a …

Title: Regional Operations Manager …
Location: Edinburgh, Scotland, United Kingdom
Connections: 156

Category: Contact NumberShow more

Kyowa Kirin Enters into License Agreement with Cerecor Inc

6 hours ago Kyowakirin.com Show details

Tokyo, Japan, March 29, 2021--Kyowa Kirin Co., Ltd. (TSE: 4151, President and CEO: Masashi Miyamoto, “Kyowa Kirin”) announced that the company has expanded its collaboration with Cerecor Inc.’s affiliate, Aevi Genomic Medicine, LLC (Rockville, MD and Chesterbrook, PA, USA, “Cerecor”) by granting Cerecor exclusive worldwide rights to develop, manufacture and …

Category: Contact NumberShow more

Cerecor Announces Drawdown of $10 Million Tranche under

3 hours ago Finance.yahoo.com Show details

About Cerecor . Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders.

Category: Contact NumberShow more

Rislenemdaz Wikipedia

8 hours ago En.wikipedia.org Show details

Rislenemdaz (developmental code names CERC-301, MK-0657) is an orally-active, selective NMDA receptor subunit 2B (NR2B) antagonist which is under development by Cerecor in the United States as an adjunctive therapy for treatment-resistant depression (TRD). In November 2013, phase II clinical trials were initiated, and in the same month, rislenemdaz received Fast Track Designation from the Food

Category: Contact NumberShow more

Cerecor Announces Positive Initial Phase 1b Results for

9 hours ago Ca.finance.yahoo.com Show details

Cerecor management will host an investor webcast and conference call today at 4:30 p.m. ET to discuss the initial Phase 1b proof-of-concept Crohn’s disease results of CERC-002, as well the next steps for the CERC-002 clinical program. Ltd. It is the only clinical-stage anti-LIGHT therapy and has the potential to treat a number of LIGHT

Category: Contact NumberShow more

CERC Earnings Date, Forecast and Report (Cerecor) MarketBeat

5 hours ago Marketbeat.com Show details

Cerecor last released its quarterly earnings results on August 1st, 2021. The reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The firm had revenue of $3.36 million for the quarter. Cerecor has generated ($0.57) earnings per share over the last year.

Category: Contact NumberShow more

An Analysis Of Cerecor Inc. (CERC) Stock – Marketing Sentinel

9 hours ago Marketingsentinel.com Show details

Cerecor Inc. (NASDAQ:CERC)’s Major holders. Insiders own 0.79% of the company shares, while shares held by institutions stand at 69.44% with a share float percentage of 70.00%. Investors are also buoyed by the number of investors in a company, with Cerecor Inc. having a total of 93 institutions that hold shares in the company.

Category: Contact NumberShow more

Ronald Marcus SVP of Medical at Karuna Therapeutics

9 hours ago Linkedin.com Show details

Terran Biosciences is a clinical stage biotech company with a number of therapeutics and Cerecor May 2015 - Nov Contact Ronald directly

Title: SVP of Medical at Karuna …
Location: Gaithersburg, Maryland, United States
1. 500+ connections

Category: Contact NumberShow more

Cerecor Inc. (NASDAQ:CERC) 28.52% Above Its 52Week Low

5 hours ago Marketingsentinel.com Show details

Cerecor Inc.’s shares saw a change of 4.92% in year-to-date performance and have moved -3.48% in past 5-day. Cerecor Inc. (NASDAQ:CERC) showed a performance of -4.48% in past 30-days. Number of shares sold short was 2.42 million …

Category: Contact NumberShow more

Cerecor Announces New Worldwide License Agreement with

9 hours ago Pharmashots.com Show details

ROCKVILLE, Md., March 29, 2021 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced that its wholly-owned subsidiary, Aevi Genomic Medicine, LLC (“Cerecor”), has entered into an expanded agreement with Kyowa Kirin Co., …

Category: Contact NumberShow more

What Are Analyst Opinions Regarding Cerecor Inc. (CERC

9 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 88.58 million. CERC does have institutional investors; and they hold 69.40% of the stock. Cerecor Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 10 new insider purchases involving 192,749 shares.

Category: Contact NumberShow more

Cerecor Inc. Closes on Initial Tranche of US $32M Series B

5 hours ago Nea.com Show details

Baltimore, MD, July 21, 2014 -- Cerecor Inc, a clinical stage biopharmaceutical company developing innovative treatments to make a difference in the lives of patients suffering from nervous system disorders, today announced the closing of the first tranche of a $32M Series B financing.The investment round was led by New Enterprise Associates (NEA), Apple Tree Partners (ATP) and MPM Capital.

Category: Contact NumberShow more

Garry Neil Chief Science Officer Avalo Therapeutics

6 hours ago Linkedin.com Show details

He has held a number of senior positions in biopharmaceutical R&D where he was responsible for maximizing existing strengths and leveraging collective resources to bring innovative new molecular

Title: Scientist, …
Location: Greater Philadelphia
1. 500+ connections

Category: Contact NumberShow more

CERC Cerecor Stock Barchart Opinion Barchart.com

1 hours ago Barchart.com Show details

The indicator value is determined by adding up the totals for the different groups and dividing this sum by the number of studies in the group. The indicator is expressed in terms of a percentage. If the total is greater than zero, then this is a "Buy". If the total is zero, then this …

Category: Contact NumberShow more

Here’s Why Cercor, Inc. (CERC) is Down on Monday

5 hours ago Investorsobserver.com Show details

Cerecor, Inc. stock is down Monday after the company signed an agreement with Kyowa Kirin Co to develop a monoclonal antibody treatment.Shares of the stock are trading lower by 5.37% to $2.82 Monday at 12:50 pm. What Caused CERC to Fall? Kyowa Kirin will receive an up-front payment from Cerecor and is eligible to receive additional payments based on achievement of regulatory and …

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Costco
Cisco
Ccu
Cae